Lataa...
Phase II cancer clinical trials for biomarker-guided treatments
The design and analysis of cancer clinical trials with biomarker depend on various factors, such as the phase of trials, the type of biomarker, whether the used biomarker, is validated or not, and the study objectives. In this article, we demonstrate the design and analysis of two Phase II cancer cl...
Tallennettuna:
| Julkaisussa: | J Biopharm Stat |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5842127/ https://ncbi.nlm.nih.gov/pubmed/28902567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2017.1372777 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|